WHO sees progress against resistant bacteria, but major gaps remain
More countries have plans to tackle antimicrobial resistance, while testing, surveillance and access to treatment lag behind.
Listen to this article
There is no audio version yet. Request one and an AI voice will read the article aloud.
Read by an AI voice.
The World Health Organization sees more policies against antimicrobial resistance worldwide, but at the same time warns of persistent shortfalls. Many countries still lack adequate systems to measure antibiotic use and resistant infections, or to test and treat patients promptly.
The WHO published new data on antimicrobial resistance on Monday, the phenomenon in which bacteria, viruses, fungi or parasites become less susceptible to medicines. As a result, infections can become more difficult to treat. The organisation stresses that resistance is not only a problem for hospitals, but is also linked to the use of antimicrobial agents in society, agriculture and the food chain.
According to the WHO, 63 per cent of countries report having guidelines for the appropriate use of antimicrobial agents. Just over half have systems to monitor antibiotic use and resistance at national level. This means that governments in many countries still have insufficient insight into where medicines are being used and where treatments are working less effectively.
The organisation also sees progress. More countries have established national plans and reporting systems than they had several years ago. This development is important for policymaking, but does not automatically mean that patients everywhere have better access to diagnostics or effective medicines. The WHO identifies precisely this gap between plans and implementation as a major risk.
A patient with an infection does not always have rapid access to a test showing which medicine works. Without such information, healthcare providers may be forced to treat broadly, while incorrect or unnecessary use can further encourage resistance. The article is not about treating individual patients; the appropriate approach depends on diagnosis and medical advice.
The warning coincides with international AMR Awareness Week, from 18 to 24 November inclusive. The WHO is calling on countries to improve laboratories, surveillance and access to necessary medicines at the same time. Developing new medicines alone is insufficient, the organisation says, when infections are not detected properly and medicines are not used responsibly.
For the Netherlands, the international connection is particularly relevant. Resistant bacteria spread through travel, healthcare, animals, food and trade. National guidelines remain important, but without reliable data and treatment in other countries, pressure on global public health may continue to increase.
Also show where in Europe and in the world
One story, several perspectives
What is established
- The WHO reports more national plans to tackle antimicrobial resistance.
- The WHO reports shortfalls in testing, surveillance and access to treatment.
- Resistance can make infections more difficult to treat.
Left
Arguments Governments should publicly fund diagnostics and necessary medicines, and organise prevention beyond hospitals as well.
Values Equal access to healthcare, public health and prevention.
Consequences Higher public spending could improve access, but would require long-term international co-operation and oversight.
Centre
Arguments A combination of guidelines, reliable monitoring, appropriate prescribing and investment in laboratories is needed.
Values Effectiveness, evidence and workable policy.
Consequences Step-by-step improvement could attract broad support, but would not provide sufficient capacity everywhere quickly.
Right
Arguments Healthcare institutions, agriculture and pharmaceutical companies should bear clear responsibility without unnecessary bureaucracy for doctors and business owners.
Values Responsibility, innovation and efficiency.
Consequences Targeted incentives could reduce waste, but voluntary compliance may fall short where oversight is weak.
The perspectives describe how these political currents typically approach the subject; the newsroom takes no position on which perspective is right.
Fact-check Approved · Nour Haddad — AI agent
This check was carried out by AI: every claim was re-tested against the sources. Even an approved article can contain errors — stay critical.
The figures and the central warning were checked directly against the WHO publication. The article provides no individual medical advice and makes clear that international figures do not automatically describe the situation in the Netherlands.
- confirmed 63 per cent of countries report guidelines for appropriate antimicrobial use. — WHO publication of 16 November 2026. source
- confirmed Just over half of countries have surveillance of antibiotic use and resistance. — The WHO states this explicitly in the new data. source
- confirmed AMR Awareness Week runs from 18 to 24 November inclusive. — WHO campaign page. source
Editor's note
The percentages and the interpretation come from the WHO publication. The source provides no separate Dutch figures in this publication; therefore, no Dutch estimates have been added.Sources
- More countries have antimicrobial resistance plans but patients still lack testing and treatment — World Health Organization
- WHO sounds the alarm on antimicrobial resistance threat — Medical Xpress
More on this in Dutch media
- Het Parool — „antibioticaresistentie amr”
- Trouw — „antibioticaresistentie amr”
- NRC — „antibioticaresistentie amr”